Community Trust & Investment Co. Has $15.18 Million Stake in IQVIA Holdings Inc. (NYSE:IQV)

Community Trust & Investment Co. raised its position in IQVIA Holdings Inc. (NYSE:IQV) by 4.9% in the fourth quarter, HoldingsChannel.com reports. The fund owned 77,240 shares of the medical research company’s stock after purchasing an additional 3,634 shares during the quarter. Community Trust & Investment Co.’s holdings in IQVIA were worth $15,178,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently modified their holdings of the company. Nordea Investment Management AB raised its stake in IQVIA by 47.4% in the fourth quarter. Nordea Investment Management AB now owns 1,405,281 shares of the medical research company’s stock valued at $277,908,000 after buying an additional 452,029 shares during the period. Simplify Asset Management Inc. lifted its holdings in IQVIA by 67.8% during the 3rd quarter. Simplify Asset Management Inc. now owns 9,637 shares of the medical research company’s stock valued at $2,284,000 after purchasing an additional 3,894 shares during the last quarter. Versor Investments LP bought a new position in IQVIA during the third quarter worth $1,328,000. JPMorgan Chase & Co. increased its holdings in shares of IQVIA by 46.2% in the third quarter. JPMorgan Chase & Co. now owns 1,845,711 shares of the medical research company’s stock valued at $437,378,000 after purchasing an additional 583,396 shares during the last quarter. Finally, CIBC Asset Management Inc raised its position in shares of IQVIA by 3.3% in the third quarter. CIBC Asset Management Inc now owns 263,752 shares of the medical research company’s stock valued at $62,501,000 after purchasing an additional 8,490 shares during the period. 89.62% of the stock is currently owned by institutional investors and hedge funds.

IQVIA Stock Performance

NYSE IQV opened at $198.12 on Wednesday. The company has a market capitalization of $35.96 billion, a price-to-earnings ratio of 26.00, a PEG ratio of 2.05 and a beta of 1.48. IQVIA Holdings Inc. has a twelve month low of $187.62 and a twelve month high of $261.73. The stock has a fifty day simple moving average of $201.43 and a 200 day simple moving average of $221.61. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 1.76.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Barclays lowered their price target on shares of IQVIA from $260.00 to $255.00 and set an “overweight” rating on the stock in a report on Friday, November 1st. BTIG Research decreased their price objective on IQVIA from $290.00 to $260.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Redburn Atlantic initiated coverage on shares of IQVIA in a research report on Monday, October 14th. They issued a “buy” rating and a $276.00 target price for the company. Royal Bank of Canada reaffirmed an “outperform” rating and set a $270.00 price target on shares of IQVIA in a research report on Wednesday, December 11th. Finally, William Blair reissued an “outperform” rating on shares of IQVIA in a report on Wednesday, December 11th. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $255.82.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.